OP0135 RISK OF CARDIOVASCULAR EVENTS UNDER JANUS KINASE INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS: OBSERVATIONAL DATA FROM THE GERMAN RABBIT REGISTER
Yvette Meißner, Katinka Albrecht, J. Kekow, S. Zinke, H. P. Tony, M. Schaefer, A. Strangfeld
Topics & Concepts
MedicineTofacitinibRheumatoid arthritisInternal medicineAbataceptRituximabLymphomaRheumatoid Arthritis Research and TherapiesCytokine Signaling Pathways and InteractionsAutoimmune and Inflammatory Disorders Research